1Tamim H,Irani-Hakime N,Aoun JP,et al.Seroprevalence of hepatitis C virus(HCV)infection among blood donors:a hospital-based study[J].Transfus Apher Sci,2001,24(1):29-35.
2Flamm SL.Chronic hepatitis C virus infection[J].JAMA,2003,289(18):2413-2417.
3Sandra S Richter.Laboratory assays for diagnosis and management of hepatitis C virus infection[J].J Clin Microbiol,2002,40(12):4407-4412.
4Castelain S,Descamps V,Thibault V,et al.TaqMan amplification system with an internal positive control for HCV RNA quantitation[J].J Clin Virol,2004,31(3):227-234.
6DiDomenico N,Link H,Knobel R,et al.COBAS AMPLICOR:fully automated RNA and DNA amplification and detection system for routine diagnostic PCR[J].Clin Chem,1996,42(12):1915-1923.
8Castro FJ,Esteban JL,Juarez A,et al.Early detection of nonresponse to interferon plus ribavirin combination treatment of chronic hepatitis C[J].J Viral Hepat,2002,9(3):202.
二级参考文献15
1Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non- responders to interferon monotherapy: a meta- analysis of individual patient data[ J ]. Gut, 2002,51:864-869.
2Papatheodoridis GV, Papadimitropoulos VC, Hsdziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus- reated cirrhosis: a meta- analysis[J] .Aliment Pnarmaool Ther, 2001,15:689- 698.
3Kjaergard LL, Krogsgaard K, Gluud C. Interfern alfa with or without ribavirin for chronic hepatitis C: systematic review of randonmised trials[J].BMJ, 2001,323:1151 - 1155.
4Alberti A, Benvegnu L. Management of hepatitis[J] .J Hepatol, 2003,38(Suppl1): S1014 - S1 18.
5Poynard T, MdHutchison J, Davis GL, et al. Impact of interferon alfa - 2b and ribavirin on progression of liver fibrosiis in patients with chronic hepatitis C[J].Hepatology, 2000,32:1131 - 1137.
6Booth JCL, O' Grady J, Neuberger J. Clinical guidelines on the mangement of hepatitis C[J]. Gut, 2001, 49(Suppl I ): il - i12.
7Chander G, Sulkowski MS, Jenckes MW, et al. Treatment of chronic hepatitis C: a systemic review[J]. Hepatology, 2002, 36(5 Suppl 1 ):S135 - S144.
8Di Ciomm no V, Russo P, Rava L, etal. Interferon alpha in the treatment of chronic hepatitis C in children: a mmeta- analysis[J] .J Viral Hepat,2003,10:210 - 214.
9Fabrizi F, Dulai G, DixitV, et al. Meta- analysis: interfeorn for the treatment of chronic hepatitis C in dialysis patients[J] .Aliment Phamacol Ther, 2003,18:1071 - 1081.
10National Institute of Health Consensus Development Conference Panel Statenent. Management of hepatitis C[J].Hepatology, 2002,36(5 Suppl 1):S3- S20.
